Format

Send to

Choose Destination
See comment in PubMed Commons below
Ned Tijdschr Geneeskd. 2012;156(6):A4227.

[Reimbursement for alternative medical treatment in the Netherlands, incomprehensible].

[Article in Dutch]

Author information

1
Universitair Medisch Centrum St Radboud, afd. Interne Geneeskunde, Nijmegen, the Netherlands. m.vandenhoogen@aig.umcn.nl

Abstract

It is remarkable that, at a time when not only doctors but also the Health Care Inspectorate (IGZ) and the health insurance companies are paying increasing attention to the quality of conventional medicine, many alternative methods of treatments without a scientific basis are accepted in the Netherlands. Even though it has been conclusively demonstrated that most alternative therapies do not work and despite the absence of scientific proof of the safety and efficacy of alternative treatments, health insurance companies do often reimburse the incurred costs. Because the safety of alternative therapies is not guaranteed, these are neither in the interest of the patient nor of society. Moreover, they are associated with considerable costs for the individual patient. By reimbursing the costs of insufficiently proven treatments, the health insurance companies are applying double standards. Reimbursement for these therapies is made at the expense of other effective and proven treatments. This can be changed through the concerted efforts of policy-makers, doctors, the IGZ, and health insurance companies.

PMID:
22316681
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Bohn Stafleu van Loghum
    Loading ...
    Support Center